Small (Weinheim an der Bergstrasse, Germany) · 2018
Drug-Controlled Release Based on Complementary Base Pairing Rules for Photodynamic-Photothermal Synergistic Tumor Treatment.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhan Qichen, Shi Xianqing, Zhou Jiahong, Zhou Lin, Wei Shaohua
Аннотация
Controlled drug release systems can enhance the safety and availability but avoid the side effect of drugs. Herein, the concept of DNA complementary base pairing rules in biology is used to design and prepare a photothermal-triggered drug release system. Adenine (A) modified polydopamine nanoparticles (A-PDA, photothermal reagent) can effectively bind with thymine (T) modified Zinc phthalocyanine (T-ZnPc, photosensitizer) forming A-PDA = T-ZnPc (PATP) complex based on A = T complementary base pairing rules. Similar to DNA, whose base pairing in double strands will break by heating, T-ZnPc can be effectively released from A-PDA after near infrared irradiation-triggered light-thermal conversion to obtain satisfactory photodynamic-photothermal synergistic tumor treatment. In addition, PDA can carry abundant Gd3+ to provide magnetic resonance imaging guided delivery and theranostic function.
Предметные рубрики MeSH
AdenineAnimalsBase PairingCell Line, TumorCombined Modality TherapyDNA, ComplementaryDelayed-Action PreparationsDrug Delivery SystemsDrug LiberationDrug SynergismFemaleHumansHyperthermia, InducedIndolesIsoindolesMiceMice, Inbred BALB CMice, NudeNanoparticlesNeoplasmsOrganometallic CompoundsPhotochemotherapyPhotosensitizing AgentsPhototherapyPolymersXenograft Model Antitumor AssaysZinc Compounds